World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

Cision PR Newswire by Cision PR Newswire
March 11, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories’ leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence.

TOULOUSE, France, March 11, 2026 /PRNewswire/ — Avène, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

In 2026, Avène will conduct a comparative clinical study to evaluate the efficacy of its new treatment for acne-prone skin, Avène Cleanance Comedomed+, in the maintenance phase following oral isotretinoin treatment in adults suffering from severe to very severe acne.

Avène is renowned for its dermatological expertise, inspired by therapeutic know-how, and has been committed to improving the treatment of skin pathologies since 1990. It is thus becoming the first brand to use Artificial Intelligence in clinical studies for dermo-cosmetics.

A concrete illustration of Pierre Fabre Laboratories’ “Supportive Care” strategy.

This study is unique in two ways: due to its scientific ambition and because it fully aligns with the “supportive care” strategy of Pierre Fabre Laboratories, launched in 2025.

“We belong to a group that has always been rooted in pharmaceuticals and dermo-cosmetics. Our medical expertise gives us a head start in understanding patients and their pathologies. We are ideally positioned to offer treatment protocols based on the pathology, combining dermo-cosmetics with medication. We are already preparing solutions to go further, by developing dermo-cosmetic innovations capable of extending and amplifying the action of the medication or delaying its necessity. Because these are dermo-cosmetics, they can be used over the long term, unlike many drug treatments,” explains Dr. Gautier Doat, Eau Thermale Avène Medical Director.

To continue reading, https://www.pierre-fabre.com/en/news/avene-artificial-intelligence-clinical-studies-dermo-cosmetics

For more information, visit www.pierre-fabre.com,  @Laboratoires Pierre Fabre, @Pierre Fabre Oncology

About Eau Thermale Avène: https://www.eau-thermale-avene.fr/

Press contact: Caroline Perdrix Thomas 
caroline.perdrix@pierre-fabre.com

*Source: GERS – SOG Early – Pharmacy Channel – Dermo-cosmetics market definition established by Pierre Fabre laboratories – Origin: Sell Out – Cumulative data up to December 2025 in volume (units) and value (revenue inc. taxes). 

Photo – https://mma.prnewswire.com/media/2930570/Avene_Cleanance.jpg
Logo – https://mma.prnewswire.com/media/2930569/PIERRE_FABRE_Avene_Logo.jpg

Pierre Fabre Avene logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/pierre-fabre-laboratories-is-exploring-the-potential-of-artificial-intelligence-to-launch-a-new-generation-of-clinical-studies-in-dermo-cosmetics-302711198.html

Cision PR Newswire

Cision PR Newswire

Related Posts

GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development

August 3, 2026

Coway Releases 21st Sustainability Report for FY2025

August 3, 2026

Shui On Land Named Among TIME’s World’s Most Impactful Companies 2026

August 3, 2026

Congolese Ambassador Marks National Day of Genocost, Calls for Deeper U.S. Partnership on Peace and Minerals

August 3, 2026

EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

August 2, 2026

Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Scottsdale Road Carwash LP, for Alleged Failure to Reimburse Employees’ Business Expenses

August 2, 2026

Popular News

  • GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development

    0 shares
    Share 0 Tweet 0
  • Shui On Land Named Among TIME’s World’s Most Impactful Companies 2026

    0 shares
    Share 0 Tweet 0
  • Coway Releases 21st Sustainability Report for FY2025

    0 shares
    Share 0 Tweet 0
  • Congolese Ambassador Marks National Day of Genocost, Calls for Deeper U.S. Partnership on Peace and Minerals

    0 shares
    Share 0 Tweet 0
  • EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler